poisar

Stocks · News reference

Neumora Therapeutics Q2 EPS $(0.23) Beats $(0.24) Estimate

Aug 14, 2026, 11:18 AMBenzinga Newsdesk

Neumora Therapeutics (NASDAQ:NMRA) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.24) by 4.17 percent. This is a 30.3 percent increase over losses of $(0.33) per share

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

NMRA
Source
benzinga
Observed
Aug 14, 2026, 11:18 AM
Checked
Aug 14, 2026, 11:18 AM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Aug 14, 2026, 11:13 AMSEC EDGAR

    8-K filing — Neumora Therapeutics, Inc. (NMRA)

    Filed: 2026-08-14 AccNo: 0001193125-26-350349 Size: 345 KB Item 2.02: Results of Operations and Financial Condition Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits

    Read original at edgar
    NMRA